Elanco Animal Health Reports Third Quarter 2021 Results Exceeding Revenue Guidance; Raising Full Year 2021 Revenue Guidance

Go back to Elanco Animal Health Reports Third Quarter 2021 Results Exceeding Revenue Guidance; Raising Full Year 2021 Revenue Guidance

Elanco Animal Health (ELAN) Tops Q3 EPS by 2c, Offers Guidance

November 5, 2021 6:35 AM EDT

Elanco Animal Health (NYSE: ELAN) reported Q3 EPS of $0.19, $0.02 better than the analyst estimate of $0.17. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.08 billion.

GUIDANCE:

Elanco Animal Health sees Q4 2021 EPS of $0.13-$0.19, versus the... More